HeartCore Reports Third Quarter 2024 Financial Results

Q3 2024 Revenues Increased 281% to $17.9 Million Q3 2024 Net Income Increased 526% to $10.8 Million NEW YORK and TOKYO, Nov. 14, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the third quarter ended […]

Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for the Phase 3 study design and ongoing partnership discussions Continued excellent safety and tolerability findings, consistent with extensive human use experience with ondansetron GLEN ALLEN, Va., Nov. 14,

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company dedicated to the global development and commercialization of cytisinicline for the treatment of nicotine dependence, today announced that Rick Stewart, CEO of Achieve Life Sciences, and management will be participating at two upcoming investor

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr. Robert Huizinga, Executive Chair of Kane Biotech have released a video outlining the details and benefits to Kane Biotech and its investors of the FB Dermatology S.R.L.

Trump Media Announces All TV Streaming Data Centers Are Fully Operational

Truth+ Content Delivery Network Operating from Sites Across the Country SARASOTA, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, is announcing today that it has completed the initial deployment of its cross-country network of data centers that

North Dakota Dental Association Endorses iCoreConnects Comprehensive Product Platform

OCOEE, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) — iCoreConnect Inc (NASDAQ: ICCT) (“iCore” or the “Company”), a leading provider of cloud-based software and technology solutions, has announced a new endorsement agreement with the North Dakota Dental Association (NDDA). The NDDA’s endorsement adds them to a growing list of state dental associations backing iCoreConnect’s full suite

Sauber Motorsports Drives Innovation with 3D Systems’ Solutions

Motorsports team adding 3D Systems’ SLA 750 Dual and PSLA 270 technology to workflow to accelerate wind tunnel testing, building on decades-long partnership Broad material portfolio combined with industry’s most advanced 3D printing technologies enables improved part quality, reduces time to part in hand 3D Systems’ solutions driving growth of additive manufacturing use in motorsports

SAIHEAT to Announce SAIHEAT BASE PLAN 2029 on BIT HEAT DAY

(NASDAQ:SAIH),(NASDAQ:SAITW), SINGAPORE, Nov. 14, 2024 (GLOBE NEWSWIRE) — SAIHEAT Limited (f/k/a SAI.TECH Global Corporation) (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW) is pleased to unveil the SAIHEAT BASE PLAN 2029, an ambitious initiative delivering integrated energy services for the nextgen data centers. Addressing the high energy demands and carbon footprint of data centers, the BASE

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

(NasdaqGM:CRSP), ZUG, Switzerland and BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that Samarth Kulkarni, Ph.D., Chief Executive Officer and Chairman of CRISPR Therapeutics, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024, at

Sky Quarry Nears Completion of First Waste Asphalt Shingle Modular Facility

(NASDAQ:SKYQ), “Modular by Design” Facility to Ensure Rapid National Expansion and is Poised to Transform the U.S. Waste-to-Energy Landscape WOODS CROSS, Utah, Nov. 14, 2024 (GLOBE NEWSWIRE) — Sky Quarry Inc. (NASDAQ: SKYQ) (“Sky Quarry” or “the Company”), an integrated energy solutions company focused on transforming the waste asphalt shingle recycling industry, today announced construction

Scroll to Top